Michael Augustyniak
Michael Augustyniak
Senior Research Associate
Michael Augustyniak joined Peptimmune in 2006 as a senior research associate as part of the pharmacology/immunology group investigating the role of PI-2301 across multiple indications including Multiple Sclerosis and Crohn's Disease. Prior to joining Peptimmune, Michael spent five years as a research associate working in the in vivo pharmacology group at NitroMed Inc. developing rodent models of inflammation and cardio-renal dysfunction. Michael received his BS in Biology from Suffolk University.
